Search Results - "Giustarini, G"
-
1
Anti-inflammatory effect of a novel locally acting A2A receptor agonist in a rat model of oxazolone-induced colitis
Published in Purinergic signalling (01-03-2018)“…Adenosine represents a powerful modulating factor, which has been shown to orchestrate the scope, duration, and remission of the inflammatory response through…”
Get full text
Journal Article -
2
Role of the A2B receptor–adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats
Published in British journal of pharmacology (01-03-2014)“…Background and Purpose Adenosine A2B receptors regulate several physiological enteric functions. However, their role in the pathophysiology of intestinal…”
Get full text
Journal Article -
3
Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats
Published in British journal of pharmacology (01-03-2014)“…Adenosine A(2B) receptors regulate several physiological enteric functions. However, their role in the pathophysiology of intestinal dysmotility associated…”
Get full text
Journal Article -
4
Fludarabine combination therapy for follicular lymphoma followed by acute myeloid leukemia: two further case records
Published in Leukemia (01-09-2008)Get full text
Journal Article -
5
Thalidomide plus Monthly High-dose Dexamethasone in Chemorefractory Myeloma. Results of a Phase II Clinical Study
Published in In vivo (Athens) (01-11-2006)“…Thalidomide is a potent anti-myeloma drug which can produce up to a 30-50% overall response rate (ORR) in pre-treated, chemorefractory multiple myeloma. Most…”
Get full text
Journal Article -
6
Low-dose thalidomide plus monthly high-dose oral dexamethasone (Thali-Dexa): results, prognostic factors and side effects in eight patients previously treated with multiple myeloma
Published in Journal of experimental & clinical cancer research (01-12-2003)“…Thalidomide is active both as single agent and in combination-therapy against refractory or relapsing multiple myeloma. Eigth patients previously treated were…”
Get more information
Journal Article -
7
Chemoresistant Myeloma: Phase II Clinical Study with Low-Dose Thalidomide Plus High-Dose Dexamethasone
Published in Journal of chemotherapy (Florence) (01-11-2004)“…Thalidomide produces a response rate from 32 to 66% of pre-treated myeloma patients with doses ranging from 100 to 800 mg/daily. Common, dose-related side…”
Get full text
Journal Article -
8
Thyroid metastases from colon cancer case report in a long term survivor
Published in Journal of experimental & clinical cancer research (01-12-2003)“…Colon cancer usually has an hematogenous spread to liver and lung: rarely, or in the case of most advanced disease, also brain and bone can be involved…”
Get more information
Journal Article -
9
Neutrophil-monocyte interplay in drug-induced liver injury
Published in Toxicology letters (10-10-2018)Get full text
Journal Article -
10
Role of the A 2B receptor–adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats
Published in British journal of pharmacology (01-03-2014)“…Background and Purpose Adenosine A 2B receptors regulate several physiological enteric functions. However, their role in the pathophysiology of intestinal…”
Get full text
Journal Article -
11
Anti-inflammatory effect of a novel locally acting A 2A receptor agonist in a rat model of oxazolone-induced colitis
Published in Purinergic signalling (01-03-2018)“…Adenosine represents a powerful modulating factor, which has been shown to orchestrate the scope, duration, and remission of the inflammatory response through…”
Get full text
Journal Article -
12
Multi-variate analysis of factors governing the pharmacokinetics of exogenous factor VIII in haemophiliacs
Published in European journal of clinical pharmacology (01-01-1988)“…The pharmacokinetics of Factor VIII was evaluated by mathematical modeling in a large-scale study in 62 haemophilia-A subjects, in whom 137 plasma Factor…”
Get full text
Journal Article -
13
Evaluation of factor VIII pharmacokinetics in hemophilia-A subjects undergoing surgery and description of a nomogram for dosing calculations
Published in American journal of hematology (01-03-1989)“…The pharmacokinetics of factor VIII were studied in a series of 20 hemophilia-A patients undergoing surgery. Regardless of the type of operation, elimination…”
Get more information
Journal Article -
14
Single-dose pharmacokinetics of factor IX evaluated by model-independent methods
Published in European journal of haematology (01-11-1987)“…We studied the pharmacokinetic data of 13 subjects with hemophilia B treated with a single-dose of a Factor IX concentrate (Bebulin TIM2, N = 9; Preconativ, N…”
Get more information
Journal Article -
15
Cancerous colonic polyps
Published in Minerva chirurgica (01-11-1996)“…The treatment of cancerous polyps of the colon has not been definitely established. In the present study the authors have brought forth their contribution on…”
Get more information
Journal Article -
16
Low risk of transmission of the human immunodeficiency virus by a solvent-detergent-treated commercial factor VIII concentrate
Published in Journal of medical virology (01-02-1992)“…A study evaluating the risk of a commercial factor VIII (FVIII) concentrate's transmitting the human immunodeficiency virus (HIV) was carried out on…”
Get more information
Journal Article